2026 Suzanne L. Baker: Neuroscience Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Neuroscience	59	3950	3617	1793	1616	249	16220

Overview

Suzanne L. Baker is affiliated with the Lawrence Berkeley National Laboratory in the United States, where their research focuses on various aspects of neuroscience and medicine. Their work prominently addresses neurodegenerative conditions, particularly Alzheimer's disease and related cognitive impairments.

The scientist's research spans multiple interconnected fields of study. The main fields include:

Medicine
Neuroscience

Within these main disciplines, Suzanne L. Baker's work further specializes in subfields such as:

Radiology, Nuclear Medicine and Imaging
Psychiatry and Mental Health
Physiology
Cognitive Neuroscience
Neurology

The primary topics explored in their research encompass:

Dementia and Cognitive Impairment Research
Alzheimer's Disease Research and Treatments
Medical Imaging Techniques and Applications
Functional Brain Connectivity Studies
Advanced MRI Techniques and Applications
Advanced Neuroimaging Techniques and Applications
Lanthanide and Transition Metal Complexes

The scientist has contributed to a number of recent papers, including:

Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET, 2020, Science Translational Medicine
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study, 2021, The Lancet Neurology
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline, 2022, Nature Medicine
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease, 2021, JAMA Neurology
Sleep Disturbance Forecasts β-Amyloid Accumulation across Subsequent Years, 2020, Current Biology

Suzanne L. Baker frequently collaborates with other researchers in their field, including:

William J. Jagust
Theresa M. Harrison
David N. Soleimani-Meigooni
Pedro Rosa-Neto
Tharick A. Pascoal

Publication venues often feature journals central to neuroscience and aging, such as:

Alzheimer's & Dementia
bioRxiv (Cold Spring Harbor Laboratory)
Journal of Neuroscience
Neurobiology of Aging
European Journal of Nuclear Medicine and Molecular Imaging

Best Publications

PET Imaging of Tau Deposition in the Aging Human Brain

Michael Schöll;Michael Schöll;Samuel N. Lockhart;Daniel R. Schonhaut;James P. O’Neil

1286
Citations
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.

Rik Ossenkoppele;Rik Ossenkoppele;Rik Ossenkoppele;Daniel R. Schonhaut;Daniel R. Schonhaut;Michael Schöll;Michael Schöll;Samuel N. Lockhart

1221
Citations
Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects

E. C. Mormino;J. T. Kluth;C. M. Madison;G. D. Rabinovici;G. D. Rabinovici;G. D. Rabinovici

798
Citations
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer's disease.

Alexandre Bejanin;Daniel R Schonhaut;Renaud La Joie;Joel H Kramer

769
Citations
Prospective longitudinal atrophy in Alzheimer’s disease correlates with the intensity and topography of baseline tau-PET

Renaud La Joie;Adrienne V. Visani;Suzanne L. Baker;Jesse A. Brown

545
Citations
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.

Elisabeth H Thijssen;Renaud La Joie;Amelia Strom;Corrina Fonseca

539
Citations
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline

Unknown

536
Citations
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease

Anne Maass;Susan Landau;Suzanne L Baker;Andy Horng

480
Citations
11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration

G. D. Rabinovici;A. J. Furst;J. P. O'Neil;C. A. Racine

426
Citations
Measurement of Longitudinal β-Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios

Susan Marie Landau;Allison Fero;Suzanne L Baker;Robert A. Koeppe

385
Citations
Relationships between Beta-Amyloid and Functional Connectivity in Different Components of the Default Mode Network in Aging

Elizabeth C. Mormino;Andre Smiljic;Amynta O. Hayenga;Susan H. Onami

364
Citations
Striatal Dopamine and Working Memory

Susan M. Landau;Rayhan Lal;James P. O'Neil;Suzanne Baker

362
Citations
Long-term evaluation of a phase 1 study of AADC gene therapy for Parkinson's disease.

Gabriele Mittermeyer;Chadwick W. Christine;Kathryn H. Rosenbluth;Suzanne L. Baker

336
Citations
Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers

S. M. Landau;S. M. Landau;B. A. Thomas;L. Thurfjell;M. Schmidt

331
Citations
Entorhinal Tau Pathology, Episodic Memory Decline, and Neurodegeneration in Aging

Anne Maass;Samuel N. Lockhart;Theresa M. Harrison;Rachel K. Bell

319
Citations
Increased metabolic vulnerability in early-onset Alzheimer’s disease is not related to amyloid burden

Gil D. Rabinovici;Ansgar J. Furst;Ansgar J. Furst;Ansgar J. Furst;Adi Alkalay;Adi Alkalay;Caroline A. Racine

318
Citations
Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data.

Suzanne L. Baker;Anne Maass;Anne Maass;William J. Jagust;William J. Jagust

300
Citations
Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.

Rik Ossenkoppele;Rik Ossenkoppele;Ruben Smith;Niklas Mattsson-Carlgren;Colin Groot

290
Citations
Longitudinal tau accumulation and atrophy in aging and alzheimer disease.

Theresa M. Harrison;Renaud La Joie;Anne Maass;Anne Maass;Suzanne L. Baker

262
Citations
Sleep as a potential biomarker of tau and β-amyloid burden in the human brain

Joseph R. Winer;Bryce A. Mander;Bryce A. Mander;Randolph F. Helfrich;Anne Maass;Anne Maass

231
Citations
Neural compensation in older people with brain amyloid-β deposition.

Jeremy A Elman;Hwamee Oh;Cindee M Madison;Suzanne L Baker

212
Citations